# Creon

NDC: 0032-2637
Generic name: Pancrelipase
Labeler / Manufacturer: AbbVie Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: CAPSULE, DELAYED RELEASE PELLETS
Routes: ORAL
Marketing started: 20231012

FDA application: BLA020725

## Active ingredients

- PANCRELIPASE AMYLASE: 180000 [USP'U]/1
- PANCRELIPASE LIPASE: 36000 [USP'U]/1
- PANCRELIPASE PROTEASE: 114000 [USP'U]/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0032-2637"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0032-2637
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=073201aa-556d-4a70-918e-84e9616fd88d